Literature DB >> 12750154

Identification of differentially expressed genes representing dendritic cell precursors and their progeny.

Heather L Wilson1, Helen C O'Neill.   

Abstract

The development of dendritic cells (DCs) from hematopoietic progenitors is not well understood. Using a spleen-derived long-term culture (LTC) system, it has been possible to continuously generate DCs from progenitors maintained in culture. The nonadherent LTC-DC population is composed of 2 major subsets. These are the small LTC-DC or DC precursors and their progeny, the large LTC-DCs that phenotypically resemble immature DCs. In this study, subtracted cDNA libraries were generated containing sequences differentially expressed in small or large LTC-DCs. Differential screening was then used on plated library clones to select genes expressed in either the small or the large cell population. Real-time polymerase chain reaction (PCR) has been used to verify the selection procedure for several genes of particular interest. Known genes isolated from subtracted libraries were related to stages in DC development and supported previous findings regarding the function of small and large LTC-DCs. Large LTC-DCs expressed a number of immunologically important genes encoding CD86, CCR1, osteopontin, and lysozyme. Small LTC-DCs resembled progenitor DCs expressing genes related to the organization of the cytoskeleton, the regulation of antigen processing, and a number of mitochondrial and ribosomal proteins. Novel transcripts were isolated from small and large LTC-DC-subtracted libraries that could encode novel proteins important in DC development. This study describes changes in gene expression related to the development of CD11c+CD11b+ major histocompatibility complex 2 low (MHC2lo) CD8alpha- DCs from precursors in a stroma-dependent culture system in the absence of exogenous cytokines.

Entities:  

Mesh:

Year:  2003        PMID: 12750154     DOI: 10.1182/blood-2002-08-2426

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Long-term in vivo imaging of normal and pathological mouse spinal cord with subcellular resolution using implanted glass windows.

Authors:  Keith K Fenrich; Pascal Weber; Mélanie Hocine; Maxime Zalc; Geneviève Rougon; Franck Debarbieux
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

2.  Regulation of RelB expression during the initiation of dendritic cell differentiation.

Authors:  Pedro J Cejas; Louise M Carlson; Despina Kolonias; Jian Zhang; Inna Lindner; Daniel D Billadeau; Lawrence H Boise; Kelvin P Lee
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

3.  Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells.

Authors:  Mari L Shinohara; Linrong Lu; Jing Bu; Miriam B F Werneck; Koichi S Kobayashi; Laurie H Glimcher; Harvey Cantor
Journal:  Nat Immunol       Date:  2006-04-09       Impact factor: 25.606

4.  Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells.

Authors:  Maddalena Illario; Maria L Giardino-Torchia; Uma Sankar; Thomas J Ribar; Mario Galgani; Laura Vitiello; Anna Maria Masci; Francesca R Bertani; Elena Ciaglia; Dalila Astone; Giuseppe Maulucci; Anna Cavallo; Mario Vitale; Vincenzo Cimini; Lucio Pastore; Anthony R Means; Guido Rossi; Luigi Racioppi
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

5.  Spleen as a site for hematopoiesis of a distinct antigen presenting cell type.

Authors:  Helen C O'Neill; Kristin L Griffiths; Pravin Periasamy; Rebecca A Hinton; Ying-Ying Hey; Sawang Petvises; Jonathan K H Tan
Journal:  Stem Cells Int       Date:  2011-11-15       Impact factor: 5.443

6.  Transplanted spleen stromal cells with osteogenic potential support ectopic myelopoiesis.

Authors:  Helen C O'Neill; Hong K Lim; Pravin Periasamy; Lavanya Kumarappan; Jonathan K H Tan; Terence J O'Neill
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.